Delivery Order SPE2DB24D2003-SPE2DB25FXLW1
- Not listed
- The Defense Logistics Agency awarded a $1,621.05 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Nexlizet 180-10 mg tablets (30-count units). This is a non-set-aside, competitively awarded contract with an ultimate completion date of August 1, 2025, and performance to be fulfilled from the vendor's Conshohocken, Pennsylvania location. The delivery order represents a child contract executed under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $2,402.40 to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Nexlizet 180-10 mg tablets in quantities of 30 units. This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 12, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for NEXLIZET 180-10 MG tablets in 30-count units, valued at $2,205.61. This firm fixed-price delivery order, with an ultimate completion date of August 1, 2025, represents a non-set-aside competitive award to the pharmaceutical distributor's Corporate Office division. The work will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $1,266.43 to AmerisourceBergen Drug Corp for the supply of Nexlizet 180-10 mg tablets (30-unit package) on August 5, 2025, with completion targeted for August 6, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award and is performed at the contractor's location in Conshohocken, Pennsylvania. As a child contract action under AmerisourceBergen's larger contract vehicle, this delivery order fulfills...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Nexlizet 180-10 mg tablets in quantities of 30 units. This firm fixed-price delivery order, valued at $1,216.50, is non-competitive and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 6, 2025. The award represents a single pharmaceutical product delivery under the company's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Nexlizet 180-10 mg tablets in a quantity of 30 units, with a ceiling value of $1,201.20. This is a firm fixed-price delivery order with an ultimate completion date of July 29, 2025, and represents a non-set-aside competitive award. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order valued at $1,256.98 to AmerisourceBergen Drug Corp for NEXLIZET 180-10 MG tablets (30-count units) on July 31, 2025, with an ultimate completion date of August 1, 2025. This competitive award, which did not utilize a set-aside designation, represents a firm fixed-price transaction for pharmaceutical delivery to support federal medical procurement needs. The order is being fulfilled from AmerisourceBergen's Corporate Office location in...
- The Defense Logistics Agency awarded a $1,487.59 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Nexlizet 180-10 mg tablets in quantities of 30, with an ultimate completion date of July 28, 2025. This non-competitive, non-set-aside delivery order was issued on July 25, 2025, and represents a routine pharmaceutical supply transaction to support federal medical procurement needs. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $1,600 to Amerisourcebergen Drug Corporation to supply 30 tablets of Nexlizet, a cholesterol-lowering medication. The contract has a period of performance from July 12-13, 2023, with performance taking place in Conshohocken, Pennsylvania. Amerisourcebergen Corporation is the parent company of Amerisourcebergen Drug Corporation, which will fulfill the order from its corporate office division. As the DLA...
- The Defense Logistics Agency Troop Support Medical awarded a $3,843.40 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 180-10 mg Nexlizet tablets to be delivered from their Conshohocken, Pennsylvania facility by August 4, 2023. Amerisourcebergen Drug Corporation is a division of Amerisourcebergen Corporation, which will perform as the prime contractor. The Defense Logistics Agency manages the Department of Defense's global supply chain and supports military treatment...
- SPE2DB24D2003Indefinite Delivery Contract
- SPE2DB24D2003-SPE2DB25FXLW1Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,946.29 to AmerisourceBergen Drug Corp for Nexlizet 180-10 mg tablets (30-count unit of use packaging) with an ultimate completion date of August 20, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The order represents a child contract under AmerisourceBergen's broader relationship with the federal government for pharmaceutical supply. This delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), a $999,999,999.00 prime vendor agreement running through December 2026 that enables global pharmaceutical support for military healthcare programs. As a critical vendor in the Defense Logistics Agency's Medical Supply Chain, AmerisourceBergen supplies pharmaceuticals and medical supplies to support military healthcare systems, including the Defense Health Agency and U.S. Coast Guard. Nexlizet is a cardiovascular medication used to lower cholesterol and uric acid levels, reflecting the company's broad portfolio of brand-name and generic medications serving federal medical procurement needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.9k | 8/19/25 |